Cercare Medical updates Neurosuite to advance stroke and oncology workflows
Advanced neuroimaging software specialist Cercare Medical has launched Cercare Medical Neurosuite Version 18, designed to deliver important innovations for stroke and oncology workflows, driven directly by clinical feedback and a continued focus on automation, usability and diagnostic confidence.
“Version 18 is about delivering tangible value where it matters most: speed, clarity and confidence in clinical decision making,” said CCO Henrik Andersen. “By improving PACS integration, introducing configurable perfusion summaries and strengthening both stroke and oncology workflows, we help clinicians work faster and more efficiently without compromising quality. This release reflects our ambition to make advanced neuroimaging easier to adopt, easier to use and more impactful in daily clinical practice.”
Søren Gildsig, chief technology officer at Cercare Medical, added: “With version 18, we introduce AI-driven technologies that improve robustness and consistency, while also refining core elements like co-registration, segmentation and reporting. These changes reflect a strong technical foundation combined with close collaboration with clinicians.”
Among the features are optimised, vertical montages for improved PACS integration; an AI-based brain mask for CT perfusion; configurable perfusion summary montage allowing clinicians to tailor how perfusion results are presented; and editable tumour segmentations with verifiied outputs (oncology).
Picture: Editable tumour segmentations.
Read this report on page 28 of the May 2026 issue of RAD Magazine.
